Pharmacological strategies to overcome treatment resistance in acute myeloid leukemia: increasing leukemic drug exposure by targeting the resistance factor SAMHD1 and the toxicity factor Top2β.
Nikolas HeroldPublished in: Expert opinion on drug discovery (2020)